An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Online
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of next-day British shipping. Vendors promote the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.
Several experts stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, risking fines, legal action or prison.
Service Reaction and Material Removal
Based on the social media company, the service has removed problematic content and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found communities with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, populated with images of slimming results, positive testimonials and step-by-step guides for preparing or injecting at home.
After moments of entering one community, a vendor shared contact information, where the majority of purchases take place. The vendor sent an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, medical conditions or past usage.
Product Information and Pricing
Within these communities, messages display black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for the messaging service stated it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.
Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious health risks”.
